**Core Concept**
Meningococcal meningitis is a severe infection caused by Neisseria meningitidis, requiring prompt antibiotic treatment to prevent complications and mortality. The choice of antibiotic is critical, as it must effectively penetrate the blood-brain barrier to target the causative organism.

**Why the Correct Answer is Right**
Ceftriaxone, a third-generation cephalosporin, is the preferred treatment for meningococcal meningitis due to its excellent penetration into cerebrospinal fluid (CSF) and broad-spectrum activity against Neisseria meningitidis. Ceftriaxone inhibits cell wall synthesis, ultimately leading to bacterial lysis and death. Its ability to cross the blood-brain barrier allows it to effectively target the meninges and prevent further infection.

**Why Each Wrong Option is Incorrect**
**Option A:** Piperacillin is a broad-spectrum penicillin, but it does not penetrate the CSF as effectively as ceftriaxone and may not be sufficient to treat meningococcal meningitis.
**Option C:** Ampicillin is a narrow-spectrum penicillin with limited activity against Neisseria meningitidis, making it an inadequate choice for treating meningococcal meningitis.
**Option D:** Meropenem is a carbapenem with broad-spectrum activity, but it is not the preferred choice for meningococcal meningitis due to its higher cost and potential for side effects compared to ceftriaxone.

**Clinical Pearl / High-Yield Fact**
When treating meningococcal meningitis, ceftriaxone should be administered promptly, ideally within 30 minutes of diagnosis, to maximize its effectiveness and reduce the risk of complications.

✓ Correct Answer: B. Ceftriaxone